Cargando…

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis

BACKGROUND: Topical immunosuppressants such as tacrolimus in different concentrations are a breakthrough in the management of recalcitrant vernal keratoconjunctivitis (VKC); however, there is a lacks of comparative studies to guide their use in VKC management. OBJECTIVE: To compare the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saha, Bhawesh Chandra, Kumari, Rashmi, Ambasta, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226287/ https://www.ncbi.nlm.nih.gov/pubmed/37255622 http://dx.doi.org/10.1177/25158414231173532

Ejemplares similares

Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)

Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019)

Treatment of balanitis of Zoon's with tacrolimus 0.03% ointment
por: Chander, Ram, et al.
Publicado: (2009)

Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis
por: Al-Amri, Abdulrahman M., et al.
Publicado: (2016)

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
por: Al-Amri, Abdulrahman Mohammed, et al.
Publicado: (2017)

Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial
por: Eltagoury, Mahmoud, et al.
Publicado: (2022)

Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis
por: Hazarika, Ajit Kumar, et al.
Publicado: (2015)

Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment
por: Leung, Alexander K. C., et al.
Publicado: (2021)

Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment
por: Chen, Qi-Quan, et al.
Publicado: (2015)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review
por: Mazzilli, Sara, et al.
Publicado: (2018)

Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs
por: Estanho, Giovana José Garcia, et al.
Publicado: (2023)

Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023)

308-nm excimer lamp with 0.03% tacrolimus ointment is safe and effective to treat children with non-segmental vitiligo
por: Li, Peishan, et al.
Publicado: (2022)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease
por: Rice, Shantini A, et al.
Publicado: (2013)

Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment
por: Kim, Hye One, et al.
Publicado: (2015)

Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03%
por: Georgakopoulou, Eleni, et al.
Publicado: (2021)

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children
por: Bourcier, Tristan, et al.
Publicado: (2022)

Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis
por: Giannaccare, Giuseppe, et al.
Publicado: (2023)

EFFECT OF 0.1% TACROLIMUS OINTMENT IN LOCALIZED VITILIGO: AN OPEN UNCONTROLLED TRIAL
por: Bhuvana, K, et al.
Publicado: (2011)

Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
por: Shoughy, Samir S, et al.
Publicado: (2016)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Vernal keratoconjunctivitis
por: Addis, Hampton, et al.
Publicado: (2018)

Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis
por: Carruthers, Jean, et al.
Publicado: (2016)

Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
por: Bhargava, Rahul, et al.
Publicado: (2019)

Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
por: Xu, Kai Man, et al.
Publicado: (2022)

Management of glaucoma in pregnancy – balancing safety with efficacy
por: Kumari, Rashmi, et al.
Publicado: (2021)

A randomized triple-blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus orabase (0.03%) in the management of oral lichen planus
por: Sivaraman, Shivakumar, et al.
Publicado: (2016)

Management of Vernal Keratoconjunctivitis
por: Leonardi, Andrea
Publicado: (2013)

LEP Design And Performance For Delta Q = 0.03
por: Keil, Eberhard
Publicado: (1979)

Effect of topical nitric oxide donors 0.03% nitroglycerin and 0.1% hydralazine on intraocular pressure in healthy canine eyes
por: Wilcox, Parker A., et al.
Publicado: (2022)

The Use of Topical Tacrolimus 0.1% Skin Ointment for Anterior Segment Conditions: A Case Series
por: Abeysiri, Poorna, et al.
Publicado: (2010)

Preparation and Properties of Ce(0.8)Sm(0.16)Y(0.03)Gd(0.01)O(1.9)-BaIn(0.3)Ti(0.7)O(2.85) Composite Electrolyte
por: Wang, Yajun, et al.
Publicado: (2022)

Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials
por: Zhao, Min, et al.
Publicado: (2022)

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis
por: Albarry, Maan Abdullah, et al.
Publicado: (2022)

Performance Optimization of Pb(0.97)La(0.03)Sc(0.45)Ta(0.45)Ti(0.1)O(3) Ceramics by Annealing Process
por: Su, Zihan, et al.
Publicado: (2023)

Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
por: Myers, Jonathan S, et al.
Publicado: (2014)

Vitiligo in association with vernal keratoconjunctivitis
por: Kumar, Sunil, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6b8lbo3vkou67avb150j46h7ti